Zoonosis, Emerging Disease, and Drug Resistance

Active Projects: 178

Project Investigator All Topics Start date
End date
Drug Resistant Malaria Clinical and Laboratory Studies Zoonosis, Emerging Disease, and Drug Resistance, Malaria
Transfusion medicine and Blood safety: Policy, Diagnostics and Standards development Mike Busch, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Transfusion Medicine, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening
Proposed Experiments to Study Emergence of Antimicrobial Resistance in Methicillin- Resistant Strains of Staphylococcus aureus Henry Chambers, MD Zoonosis, Emerging Disease, and Drug Resistance
Host Protein Degradation by Schistosome Parasites Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Applied Research on Antimicrobioal Resistance: Molecular Epidemiology of Community Methicillin-resistant Staphylococcus aureus (MRSA) Henry Chambers, MD Zoonosis, Emerging Disease, and Drug Resistance
Hemin Receptor Gene Family of Bartonella quintana Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
Genomic and Clinical Correlates of Human Bartonella Quintana Infection Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
Targeting Cysteine Proteases--Antiparasitic Chemotherapy Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Enfuvirtide Intensification for Multi-Drug Resistant HIV Steven Deeks, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Pharmacology and Drug Treatment
Translational Studies of Antimalarial Drug Resistance Philip J. Rosenthal, MD Zoonosis, Emerging Disease, and Drug Resistance, Malaria
Cap Independent Translation of Dengue Virus Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance
Valley Fever Vaccine Project George Rutherford, MD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development
High Throughput Assay for Screening Compounds Against T. Brucei Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Optimization of Cysteine Protease Inhibitors Targeting Trypanosoma Brucei Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Schistosoma mansoni: Identification and Validation of New Targets for Therapy Using a siRNA Screen Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Transcriptional Responses of Parasite and Host during Intestinal Colonization and Invasion by Entamoeba histolytica Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Predicting and Improving Critical Outcomes for Bacterial Keratitis Nisha Acharya, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Predicting and Improving Outcomes in Bacterial and Fungal Keratitis Nisha Acharya, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
UCDRD Whitepaper: Viral Pathogens Joseph Derisi, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
A Clinical Trial for Uncomplicated Skin Infections in Areas of Epidemic Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Henry Chambers, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
Bartonella Virulence Mechanisms in Patients with AIDS Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS
Multidrug-Resistant CA-MRSA Infections Among HIV+ Persons: CA AIDS Grant ID07-REI-129 Henry Chambers, MD Infectious Disease, Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Epidemiology and Surveillance
Trypanosome Drug Development Consortium Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Identification of Novel Small Molecule Therapeutics for Visceral Leishmaniasis Adam Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Janssen/Sakanari - flubendazole study 20150930 Judy Sakanari, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
HIV Emergence of Drug Resistance Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Pharmacology and Drug Treatment
The Incidence of Bacillary Angiomatosis in Uganda Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
Virus population dynamics, genetic diversity and evolution Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance
Detection and Discovery of Viral Pathogens Associated with Dengue-like Symptoms in Nicaragua Joseph Derisi, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance
Core B: Intracellular Pathogens and Innate Immunity Joseph Derisi, PhD Zoonosis, Emerging Disease, and Drug Resistance, Immunology
Regulation of the Development of Trypanosoma brucei Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Prevention of Emergence of Antibiotic Resistant P. aeruginosa Zoonosis, Emerging Disease, and Drug Resistance
Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies Philip J. Rosenthal, MD Zoonosis, Emerging Disease, and Drug Resistance, Malaria
Microbial Pathogenesis and Host Defense Joanne Engel, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Training International Scholars and Clinicians
Utility of Contact Investigation of Drug Susceptible and Resistant Tuberculosis in Tanzania Elizabeth Fair, PhD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Epidemiology and Surveillance
Identification of Anti-HIV Lead Compounds Targeting Adam Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS
CDC Preparedness and Emergency Response Research Center Travis Porco, PhD, MPH Zoonosis, Emerging Disease, and Drug Resistance
Subcontract Work in Association with LLNL LDRD Project: COMP-08ERD036 Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Quasispecies and drug resistance Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance
Valley Fever Vaccine Project 2010 George Rutherford, MD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development
Student and Postdoctoral Collaborations Travel Award Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Residencies, Fellowships, and Postdoctoral Training
Bartonella henselae: Mechanisms of Chronic Bloodstream Infection Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
Comprehensive Diagnostics for Viral Encephalitis/Meningitis Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Comprehensive Diagnostics for Viral Encephalitis/Meningitis Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
A Rapid Pan-Viral Microarray Diagnostic for Category A-C Biodefense Pathogens Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Expanded Access to MGAWN1 in Subjects with Suspected West Nile Neuroinvasive Disease; Substantial Exposure, or Infection and a Compromised Immune System Jeffrey Ralph, MD Zoonosis, Emerging Disease, and Drug Resistance, Pharmacology and Drug Treatment
Tuberculosis guidelines and best practices internationally Sarah Royce, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis
Identification of Novel Small Molecule Therapeutics for Visceral Leishmaniasis Adam Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Iron-Dependent Drug Delivery as a New Paradigm in Anti-Parasitic Chemotherapy and Prophylaxis Adam Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Programmable Genetic Memory in Bacteroides: Diagnosis of Diarrheal Disease Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Pediatrics, Newborn and Infant Health
Genetics of Brazilian Populations Mark Seielstad, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Transfusion Medicine, Genetics, Epidemiology and Surveillance
Chemical Methods for Ferrous Iron Targeted Drug Delivery Adam Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, Malaria
Systems-Based Analysis of Flaviviral Host Restriction Nevan Krogan, PhD, MSc Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Viral Discovery in Human and Animal Samples Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Structure-Aided Design of CYP51 Inhibitors for Treatment of Parasitic Infections Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
A New Field Assay to Diagnose and Monitor Schistosomiasis Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Vitamin A Metabolism and Helminth Infection Mike McCune, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Linking Virus Population Genetic Structure to Infectivity and Adaptation Raul Andino-Pavlovsky, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
Multiplexed Viral and Cytokine Response Assays Using NanoString Technology Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
California Emerging Infections Program Ina Park, MD Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance, Health Systems Strengthening, UCSF Professional Education
Using Pan-Pathogen Microarrays and Deep Sequencing to Search for the Cause of Southern Tick-Associated Rash Illness (STARI) Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance
The PIP2-Virus Interface and PI 4-Kinase: Novel Biology and Validation Targets Kevan Shokat, PhD Zoonosis, Emerging Disease, and Drug Resistance
Host-pathogen Interactions during Vertical Transmission of Listeria monocytogenes Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Women's Health, Labor and Delivery, Newborn and Infant Health
Trefoil Factors Regulate Th2 Immunity Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Immunology
Trial of T.cruzi DNA Vaccine in Experimental Model of Disease Challenge Infection Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Designing Selective Inhibitors of Calcium-Dependent Kinases in Parasites Kevan Shokat, PhD Zoonosis, Emerging Disease, and Drug Resistance
Novel Mechanisms of Beta-Lactam Resistance in Staph aureus Henry Chambers, MD Zoonosis, Emerging Disease, and Drug Resistance
Clin 0004 Characterization of Viral Hemorrhagic Fevers of Unknown Origin Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Clin 0003 Identification and Characterization of a Putative Novel Poxvirus in the DRC Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Identification of Signaling Pathways Associated with Lyme Disease Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
HARC Center: HIV Accessory and Regulatory Complexes Alan Frankel, PhD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Immunology
Pathogen Discovery in PREDICT Human and Wildlife samples to Detect and Identify Viruses Present, Both Known and Novel Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Regulation of Virulence Traits in a Fungal Pathogen of Cancer Patients Zoonosis, Emerging Disease, and Drug Resistance, Occupational and Environmental Disease
Identifying inhibitors of Parasitic Worm Activity Zoonosis, Emerging Disease, and Drug Resistance
C. elegans as a Targeted Molecular Surrogate for Filarid Parasites 2 Kaveh Ashrafi, PhD Zoonosis, Emerging Disease, and Drug Resistance
Chemical Methods for Ferrous Iron Dependent Drug Delivery Adam Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Broad Spectrum Antivirals Targeting Envelope Proteolysis and Viral Uncoating Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Antibacterial Resistance Leadership Group (ARIG) Henry Chambers, MD Zoonosis, Emerging Disease, and Drug Resistance, Systematic Reviews and Guideline Development
2013 NIH Workshop on Protein Homeostasis and Viral Infection Raul Andino-Pavlovsky, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
A schistosome cysteine protease in Th response polarization Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Identification and Validation of Targets of Phenotypic High Throughput Screening Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Kinetoplastid Drug Development: Strengthening the Preclinical Pipeline Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Harvesting of S. Mansoni schistosoma eggs Zoonosis, Emerging Disease, and Drug Resistance
Non-invasive diagnosis of viable adult filarial infections Judy Sakanari, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Novel Maltodextrin-Based, Bacterial Targeting Probes for Bioimaging of Viable MTB In Vivo Payam Nahid, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development
Fighting emerging antimalarial drug resistance Philip J. Rosenthal, MD Zoonosis, Emerging Disease, and Drug Resistance, Malaria
Chlamydial sexually transmitted diseases and trachoma Deborah Dean, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness, Drug and Diagnostics Development
Predictors of Cardiomyopathy Progression in a Cohort of Bolivian Patients with Chagas Disease Caryn Bern, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Cardiovascular Disease
International Clinics on Infectious Disease Dynamics and Data (ICI3D Program) Travis Porco, PhD, MPH Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Training International Scholars and Clinicians
Integrative Pharmacology Approach to Understand Mechanisms of Tuberculosis Drug Resistance Rada Savic, PhD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development
De Facto Monotherapy during Multidrug Tuberculosis Treatment and Emergence of Resistance Rada Savic, PhD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
Advancing Broad Spectrum Host-Targeting Antiviral Strategies to the Clinic Kevan Shokat, PhD Zoonosis, Emerging Disease, and Drug Resistance
Interaction between Innate and Th2 Lymphocytes in Helminth Immunity Jesse Nussbaum, MD Zoonosis, Emerging Disease, and Drug Resistance
Epidemiology of leishmaniasis and schistosomiasis Donald Heyneman, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Lead Identification to Clinical Candidate Selection: Drugs for Chagas' Disease Adam Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance
Immunology & epidemiology of intestinal infectious diseases Robert Owen, MD Zoonosis, Emerging Disease, and Drug Resistance, Immunology, Epidemiology and Surveillance
Travel Medicine in Global Health Mary Wilson, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Trefoil Factor Proteins Modulate Host Immunity against Hookworms Zoonosis, Emerging Disease, and Drug Resistance, Immunology
Serological prevalence of viral hemorrhagic fevers in Equatorial Africa Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
Analysis of the rapid policy change toward empirical treatment of fever with artemisinin-based combination therapy in Ebola-burdened areas of Liberia Matt Susko, MS Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Policy and Standards of Care
Sanitation, Water, and Instruction in Face-washing for Trachoma (SWIFT) Jeremy Keenan, MD, MPH Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Pathogen characterization and discovery by deep sequencing of two major vectors associated with Lyme disease and other tickborne infections Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Metabiota - Viral Surveillance for the PREDICT Program 20150410 Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Processing Uganda Swabs for Trachoma Alternative Indicators Study Julius Schachter, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Targeting host autophagy for treating Mtb infections and synergizing with antibiotics in vivo Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Pharmacology and Drug Treatment
Resistance of Malaria Parasites to Artemisinin-Based Therapies Philip J. Rosenthal, MD Zoonosis, Emerging Disease, and Drug Resistance, Malaria
Auranofin supplies to test as a macrofilaricide for human onchocerciasis Jaime Sepulveda, MD, DSc, MPH Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Philippine-UC Collaboratory for Device Innovation (Education/Training Award) Michael Harrison, MD Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Drug and Diagnostics Development, Genetics, Training International Scholars and Clinicians
RAPID: Ebola virus population structure, genetic diversity and evolution Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development, Pharmacology and Drug Treatment
Quantitative mapping of interactions between dengue virus and its hosts Zoonosis, Emerging Disease, and Drug Resistance, Immunology
CCD Study- RNA Sequencing Charles Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Optimal MDR treatment in children Rada Savic, PhD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
Gene circuits that control morphology in Histoplasma Anita Sil, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
Prevalence of baseline and longitudinal heteroresistant M. tuberculosis and association with patient-important outcomes John Metcalfe, MD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
Identifying the role of opportunistic pathogens including Giardia, Cryptosporidia, Microsporidia and Mycobacterium avium Robert Owen, MD Opportunistic Infection, Zoonosis, Emerging Disease, and Drug Resistance, Occupational and Environmental Disease
Disease susceptibility and global distribution of genetic variation Mark Seielstad, PhD HIV/AIDS, Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Transfusion Medicine, Genetics, Epidemiology and Surveillance
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
Real-Time Detection of Bloodborne Pathogens by Unbiased Nanopore Sequencing 20150506 Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus, Continuation A120553 Henry Chambers, MD Zoonosis, Emerging Disease, and Drug Resistance
Naturally acquired immunity to norovirus in a newborn cohort in Peru Caryn Bern, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Newborn and Infant Health
Novel methods for monitoring long-term drug exposure and resistance amplification during treatment of multidrug resistant tuberculosis John Metcalfe, MD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development
Treating Snake Envenomation in India: A Costing Analysis for the Adoption of a Small Molecule Therapeutic Simran Dhanju, MS Zoonosis, Emerging Disease, and Drug Resistance
Novel methods of pharmacologic monitoring for multidrug resistant tuberculosis treatment in the setting of HIV infection John Metcalfe, MD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
Host-Directed Strategies to Create Synergistic Antibacterial Therapies Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development, Immunology
New approaches to study Pseudomonas-host interactions Joanne Engel, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance
Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore Sequencing Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Profiling of Collaborator's Small Molecule Anti-filarials Judy Sakanari, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Development of the infant gastrointestinal virome and shedding of oral polio and rotavirus vaccines in Bangladeshi and US infants Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Newborn and Infant Health
The Impact of WASH on Re-infection with STH Jeremy Keenan, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Epidemiology and Surveillance, Risk Reduction and Prevention
Epidemiology of vector borne diseases Isabel Rodriguez Barraquer, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance
Bartonella: dissecting niche-specific adaptation in a human pathogen Zoonosis, Emerging Disease, and Drug Resistance
Phase 1 Train of Na-APR-w and Na-GST-1 Hookworm Vaccine in Brazilian Adults Bryan Greenhouse, MD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Snakebite treatment in Nepal Tommaso Bulfone, MS Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Mass Treatment of Soil-Transmitted Helminths as a Platform for National Cooperation and Action in Peru: Xochilt Borja, MS Zoonosis, Emerging Disease, and Drug Resistance, Health Economics and Effectiveness
he Efficacy of Various Antibiotics at Targeting Wolbachia for the Treatment of Lymphatic Filariasis Emma Gunderson, MS Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development, Pharmacology and Drug Treatment
Sustained Strengthening of Public Health Laboratory, Transfusion Services and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia Kayla Enriquez, MD, MPH Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Transfusion Medicine, Drug and Diagnostics Development, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening, Training International Scholars and Clinicians
Fellowship - Award - 2016-2017 Pathogenesis and Treatment of Ebola-Associated Uveitis Rationale Nisha Acharya, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Selective AAK1 and GAK inhibitors for combating Dengue and other emerging viral infections Raul Andino-Pavlovsky, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Immunology
Novel Therapeutics for Treatment of River Blindness and Lymphatic Filariasis Judy Sakanari, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
UC Valley Fever Research Initiative Anita Sil, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Genetics
Vertical Transmission of Zika Virus: Placental Histopathology and Fetal Outcomes Stephanie Valderramos, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neurology and Mental Health, Newborn and Infant Health
Pathogen discovery and epidemiology in tick vectors associated with Lyme-like diseases Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance
INTERCEPT: Interfering and Co-evolving Prevention and Therapy Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
International Clinical Research Fellowship Christopher Stewart, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal Grant Dorsey, MD Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Epidemiology and Surveillance
A Combined Pathogen-Host Sequencing Assay for Diagnosis of Lyme and Other Tickborne Infections Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Attitudes and Perceptions of a Musical Intervention "Iculo Ngenyoka" for Snakebite Awareness in Swaziland: A Qualitative Study Liam Erickson, MS Zoonosis, Emerging Disease, and Drug Resistance, Patient and Peer Education
Drug-Resistant Tuberculosis on the Texas-Mexico Border: Improving the Quality of bi-national TB Projects Camila Hurtado, MS Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
Understanding the Effects of Snake Envenomation in Livestock on the Lives of Farmers in the Southern Pacific Region of Costa Rica Andrea Nickerson, MS Zoonosis, Emerging Disease, and Drug Resistance
Whole Genome Sequence Characterization of Drug Resistant Malarial Strains Sumayya Mohammed, MS Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Genetics
Community Perceptions of Intestinal Infections in the Sorsogon Province, the Philippines Ekaterina Tangog , MS Zoonosis, Emerging Disease, and Drug Resistance
A Randomized, Double-blind, Placebo-controlled Clinical Trial of Fluconazole as Early Empiric Treatment of Coccidioidomycosis Pneumonia (Valley Fever) in Adults Presenting with Community Acquired Pneumonia (CAP) in Endemic Areas (FLEET-Valley Fever) Mohamed Fayed, MD Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance
The impact of antimalarial resistance on malaria transmission in Uganda Melissa Conrad, PhD Zoonosis, Emerging Disease, and Drug Resistance, Malaria
Leveraging mosquito antiviral immunity to detect viral infections: Towards a scalable field-based approach for predicting arbovirus epidemics Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance
Building Evidence for Advancing New Treatment For XDR/XDR-TB (BEAT TUBERCULOSIS) Study Patrick Phillips, PhD, MS, MA Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Pharmacology and Drug Treatment
The M-PulSe Study: Detecting Pulmonary Edema in Sepsis with Lung Ultrasonography in Malawi Richard J. Wang, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
How Zika virus disrupts neuronal cellular architecture Jeremy Reiter, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance
Dissecting the effect of paracrine responses to Zika virus on neurodevelopment in the human brain Hanna Retallack, AB Zoonosis, Emerging Disease, and Drug Resistance, Immunology
HPMI: Host Pathogen Mapping Initiative Nevan Krogan, PhD, MSc Zoonosis, Emerging Disease, and Drug Resistance, Immunology, Genetics
The impact of vector control interventions on adverse birth outcomes. Michelle Roh, MPH Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Women's Health, Newborn and Infant Health
Insect adaptive immunity Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance
Chemical Methods for Ferrous Iron Dependent Drug Delivery Adam Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance
PREDICT-2 Dean Jamison, PhD Zoonosis, Emerging Disease, and Drug Resistance, Risk Reduction and Prevention
Chagas Caryn Bern, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Visceral leishmaniasis control in India Caryn Bern, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Simcere Surpi eval project Charles Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Host-pathogen interactions: Unveiling common mechanisms for rewiring host factors in infectious processes Nevan Krogan, PhD, MSc Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Immunology, Genetics
EV71 intra-host evolution, attenuation and vaccine development Raul Andino-Pavlovsky, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men Anne Luetkemeyer, MD Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance
Identification of Cobra-specific antibodies Charles Craik, PhD Zoonosis, Emerging Disease, and Drug Resistance, Immunology
Review of modeling studies used in WHO guidelines Nathan Lo, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Policy and Standards of Care, Systematic Reviews and Guideline Development
Understanding the epidemiology and natural history of unrecognized Ebola virus infection Dan Kelly, MD, MPH Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development, Epidemiology and Surveillance
Prevalence, incidence and risk factors for genital and rectal C. trachomatis and N. gonorrhoeae infections and antibiotic resistance in Fiji Deborah Dean, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance
New Serological Measures of Infectious Disease Transmission Intensity Benjamin F. Arnold, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Epidemiology and Surveillance
Estimating the burden of arboviruses in Uganda using age-stratified serological data Isabel Rodriguez Barraquer, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance
Ebola modeling: behavior, asymptomatic infection, and contacts Travis Porco, PhD, MPH Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance
Investigating interactions between pesticide exposures and susceptibility to Zika virus infection in the human placenta Stephanie Gaw, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Occupational and Environmental Disease, Newborn and Infant Health
AVENIR: Assessing the impact of azithromycin on child mortality in Niger Thomas Lietman, MD Zoonosis, Emerging Disease, and Drug Resistance, Pharmacology and Drug Treatment, Pediatrics, Newborn and Infant Health, Health Economics and Effectiveness

Active Investigators: 1